Table 3.
Study site (reference) | |||||||||
---|---|---|---|---|---|---|---|---|---|
UK† (2) | South Africa¥ (2) | Germany (5) | UK/France (6) | ||||||
Gene | n | Value [95% CI] | n | Value [95% CI] | n | Value [95% CI] | n | Value [95% CI] | |
DOCK9 | AUC (HD vs. TB) | 0.79 [0.66–0.92] | 0.80 [0.66–0.95] | 0.53 [0.28–0.82] | 0.93 [0.84–1.0] | ||||
Specificity (%) | 24 | 96 [79–100] | 31 | 97 [83–100] | 18 | 94 [73–100] | 52 | 96. [87–100] | |
Sensitivity (%) | 34 | 15 [5–31] | 20 | 35 [15–59] | 8 | 13 [0.3–53] | 11 | 82 [48–98] | |
EPHA4 | AUC (HD vs. TB) | 0.79 [0.66–0.91] | 0.92 [0.85–1.0] | 0.85 [0.69–1.0] | 0.90 [0.79–1.0] | ||||
Specificity (%) | 24 | 96 [79–100] | 31 | 97 [83–100] | 18 | 94 [73–100] | 52 | 962 [87–100] | |
Sensitivity (%) | 34 | 24 [11–41] | 20 | 75 [51–91] | 8 | 63 [25–92] | 11 | 55[23–83] | |
NPC2 | AUC (HD vs. TB) | 0.95 [0.91–1.0] | 0.97 [0.93–1.0] | 0.99 [0.95–1.0] | 0.99 [0.97–1.0] | ||||
Specificity (%) | 24 | 96 [79–100] | 31 | 97 [83–100] | 18 | 94 [73–100] | 52 | 96 [87–100] | |
Sensitivity (%) | 34 | 82 [66–93] | 20 | 85 [66–97] | 8 | 100 [63–100] | 11 | 91 [58–100] | |
†Study population composed of immigrants from endemic countries or household contacts.
¥HD samples were not available; therefore, ROC analysis was performed comparing latently infected subjects and TB patients.